Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José M Gatell

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Efficacy of raltegravir: from healthy volunteers to phase III trials]José M Gatell
AIDS Reviews|March 4, 2014
Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatmentChristian Manzardo, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|April 11, 2015
[Position of dolutegravir in the treatment of HIV infection]Esteban Martínez, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|December 28, 2014
[Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection]Laura Zamora, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Secondary effects associated with raltegravir]José M Gatell, Laura Zamora
Current Opinion in Infectious Diseases|June 18, 2009
Cardiovascular disease and HIV infection: host, virus, or drugs?Esteban Martínez, María Larrousse, José M Gatell
The Journal of Antimicrobial Chemotherapy|October 19, 2012
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL studyMar Masiá, Esteban Martínez, Sergio Padilla, et al.
Antiviral Therapy|November 13, 2004
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapyEsteban Martínez, Montserrat Tuset, Ana Milinkovic, et al.
AIDS Research and Human Retroviruses|August 25, 2012
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravirEsteban Martínez, Polyana M d'Albuquerque, Ignacio Pérez, et al.
Journal of Leukocyte Biology|August 9, 2007
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3Marta Rodríguez-García, Harold Oliva, Núria Climent, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Efficacy of raltegravir: from healthy volunteers to phase III trials]José M Gatell
AIDS Reviews|March 4, 2014
Stribild® (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate): a new paradigm for HIV-1 treatmentChristian Manzardo, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|April 11, 2015
[Position of dolutegravir in the treatment of HIV infection]Esteban Martínez, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|December 28, 2014
[Efficacy of initial antiretroviral therapy based on lopinavir/ritonavir plus 2 nucleoside/nucleotide analogs in patients with human immunodeficiency virus type 1 infection]Laura Zamora, José M Gatell
Enfermedades Infecciosas Y Microbiologia Clinica|July 3, 2009
[Secondary effects associated with raltegravir]José M Gatell, Laura Zamora
Current Opinion in Infectious Diseases|June 18, 2009
Cardiovascular disease and HIV infection: host, virus, or drugs?Esteban Martínez, María Larrousse, José M Gatell
The Journal of Antimicrobial Chemotherapy|October 19, 2012
Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL studyMar Masiá, Esteban Martínez, Sergio Padilla, et al.
Antiviral Therapy|November 13, 2004
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapyEsteban Martínez, Montserrat Tuset, Ana Milinkovic, et al.
AIDS Research and Human Retroviruses|August 25, 2012
Abacavir/lamivudine versus tenofovir/emtricitabine in virologically suppressed patients switching from ritonavir-boosted protease inhibitors to raltegravirEsteban Martínez, Polyana M d'Albuquerque, Ignacio Pérez, et al.
Journal of Leukocyte Biology|August 9, 2007
Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3Marta Rodríguez-García, Harold Oliva, Núria Climent, et al.
Pageof 11